Author:
Kiley Jessica W.,Shulman Lee P.
Publisher
Springer International Publishing
Reference105 articles.
1. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies. Lancet. 1996;347:1713–27.
2. Rosenblatt KA, Gao DL, Ray RM, et al. Oral contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control. 2009;20:27–34.
3. Marchbanks PA, McDonald JA, Wilson HG, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med. 2002;346:2025–32.
4. Vessey M, Yeates D, Flynn S. Factors affecting mortality in a large cohort study with special reference to oral contraceptive use. Contraception. 2010;82:221–9.
5. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Hormonal contraceptives, progestogens only. In: Hormonal contraception and post-menopausal hormonal therapy; IARC monographs on the evaluation of carcinogenic risks to humans, vol 72. Lyon: IARC Press; 1999, pp. 339–97. ISBN 92-832-1272-X.